Provided by Tiger Trade Technology Pte. Ltd.

Janux Therapeutics, Inc.

13.69
+0.32002.39%
Volume:396.00K
Turnover:5.37M
Market Cap:823.42M
PE:-8.15
High:13.77
Open:13.37
Low:13.37
Close:13.37
52wk High:35.34
52wk Low:12.12
Shares:60.15M
Float Shares:44.97M
Volume Ratio:0.74
T/O Rate:0.88%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.6802
EPS(LYR):-1.2836
ROE:-12.48%
ROA:-10.49%
PB:0.84
PE(LYR):-10.67

Loading ...

Jan 26, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jan 23, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jan 22, 2026

Major Issues Report

Form 8-K - Current report
Dec 15, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Dec 08, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Dec 03, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Dec 01, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Nov 14, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Nov 06, 2025

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Nov 06, 2025

Major Issues Report

Form 8-K - Current report
Oct 28, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Sep 19, 2025

Major Issues Report

Form 8-K - Current report
Aug 07, 2025

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 07, 2025

Major Issues Report

Form 8-K - Current report
Jun 13, 2025

Major Issues Report

Form 8-K - Current report
May 09, 2025

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
May 08, 2025

Major Issues Report

Form 8-K - Current report
May 01, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Apr 22, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Mar 04, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities